<DOC>
	<DOCNO>NCT00371215</DOCNO>
	<brief_summary>The purpose study evaluate whether rThrombin safe use control bleed skin graft surgery .</brief_summary>
	<brief_title>Study Recombinant Human Thrombin Bleeding During Autologous Skin Grafting</brief_title>
	<detailed_description>This Phase 2 multiple site , single-arm , open-label study design evaluate safety rThrombin subject age 2 75 year receive partial- full-thickness autologous sheet mesh graft follow burn traumatic skin injury . After establish eligibility , study participant treat topical spray rThrombin skin graft recipient site autologous skin graft surgery . There 1-month follow-up period surgery .</detailed_description>
	<mesh_term>Thrombin</mesh_term>
	<criteria>Autologous skin graft sheet mesh graft follow burn traumatic skin injury Known antibody hypersensitivity thrombin coagulation factor</criteria>
	<gender>All</gender>
	<minimum_age>2 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>March 2009</verification_date>
	<keyword>hemostasis</keyword>
	<keyword>grafting , skin</keyword>
	<keyword>hemostatics</keyword>
	<keyword>phase 2</keyword>
</DOC>